2026-03-18T19:29:03-05:00 2025-06-30 410746749 CLIFTONLARSONALLEN LLP 301 SW ADAMS STREET SUITE 1000 PEORIA IL 61602 990 2024-07-01 260303542 HOOSIER CANCER RESEARCH NETWORK INC HOOS 3179212050 7676 INTERACTIVE WAY 120 INDIANAPOLIS IN 46278 BRIAN STEMME CEO 3179212050 2026-03-11 1 1 ANDREW SMITH CPA P01518894 3096714500 2026-03-11 2024 2025-03-06 01:10:19Z BRIAN STEMME 7676 INTERACTIVE WAY 120 INDIANAPOLIS IN 46278 17247855 0 X WWW.HOOSIERCANCER.ORG X 2007 IN TO REDUCE THE BURDEN OF CANCER BY ADVANCING CANCER RESEARCH, EDUCATION, AND PATIENT ADVOCACY. 10 4 63 10 0 0 7792 389971 13602952 14970336 286702 403050 0 0 13897446 15763357 0 0 0 0 5252112 5798996 0 0 0 8959647 9477672 14211759 15276668 -314313 486689 14561673 14903245 4796232 4508801 9765441 10394444 TO FORM UNPARALLELED RELATIONSHIPS BETWEEN ACADEMIC, COMMUNITY, PHARMACEUTICAL, AND BIOTECH COLLABORATORS WITH THE GOAL OF ADVANCING CANCER RESEARCH, EDUCATION, AND PATIENT ADVOCACY. 0 0 12237978 0 13734404 INVESTIGATOR-INITIATED STUDIES - THESE ARE STUDIES CREATED BY NON-INDUSTRY PHYSICIANS, MOST COMMONLY FOR US FROM ACADEMIC INSTITUTIONS BUT POSSIBLY ALSO FROM COMMUNITY SITES, AND THOSE PHYSICIANS SERVE AS SPONSOR-INVESTIGATORS. WHEN WE CONDUCT/MANAGE THESE STUDIES, WE PRESERVE RIGHTS FOR US AND OUR MEMBER INSTITUTIONS TO PUBLISH AND ACCESS DATA FOR THE PUBLIC BENEFIT CONSISTENT WITH OUR TAX EXEMPT PURPOSE. THESE STUDIES MAY BE FUNDED BY INDUSTRY, BUT INDUSTRY IS NOT THE SPONSOR. THESE STUDIES MAY ALSO BE FUNDED BY PHILANTHROPIC ORGANIZATIONS, AND IN SOME CASES PUBLIC AND PRIVATE UNIVERSITIES. THE SPONSOR INVESTIGATOR OWNS THE PROTOCOL AND DATA IN AN IIT AND INDUSTRY GETS TO USE THE DATA. 1021131 0 848432 INDUSTRY-SPONSORED STUDIES - ON RARE OCCASIONS, WE GET INVOLVED IN INDUSTRY-SPONSORED STUDIES, MEANING A STUDY INITIATED AND CONDUCTED BY A PHARMACEUTICAL COMPANY. WHEN WE WORK ON THOSE STUDIES, WE PRESERVE RIGHTS FOR US AND OUR SITES TO PUBLISH AND ACCESS DATA FOR THE PUBLICBENEFIT CONSISTENT WITH OUR TAX-EXEMPT PURPOSE. PHARMA FUNDS THESE STUDIES AND ALSO ACTS AS THE SPONSOR. PHARMA OWNS THE PROTOCOL AND DATA IN THESE STUDIES, AND SITES (AND WE) GET TO USE THE DATA FOR PUBLICATION PURPOSES. 409012 0 387500 BTCRC ADMINISTRATION - HCRN IS THE ADMINISTRATIVE HEADQUARTERS OF THE BIG TEN CANCER REASEARCH CONSORTIUM (BTCRC). EACH MEMBER INSTITUTION PAYS IN DUES WHICH SUPPORT CONSORTIUM OPERATIONS INCLUDING THE BTCRC CHIEF SCIENTIFIC OFFICER, WORKING GROUP COORDINATION, LOI DEVELOPMENT, EVENT MANAGEMENT, AND OVERHEAD. THE BTCRC IS LED BY A STEERING COMMITTEE COMPOSED OF ONE RESEARCHER FROM EACH MEMBER INSTITUTION. 13668121 1 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 17 0 1 63 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 4 0 0 0 0 0 1 0 1 1 0 0 0 1 1 1 1 1 1 0 0 X MARK INGOLD 3179212050 7676 INTERACTIVE WAY SUITE 120 INDIANAPOLIS IN 46278 PATRICK LOEHRER MD BOARD MEMBER 0.50 40.00 X 0 248881 0 CHRIS WAYNE TREASURER 0.50 40.00 X X 0 119788 0 BROOKE PATZ BOARD MEMBER 0.50 40.00 X 0 118932 0 RITA ASSI MD BOARD MEMBER 0.50 40.00 X 0 52360 0 JENNIFER KING MD BOARD MEMBER 0.50 40.00 X 0 52030 0 TIM LAUTENSCHLAEGER MD BOARD MEMBER 0.50 40.00 X 0 41274 0 CHRIS FAUSEL PHARMD CHAIR 1.00 0.00 X X 0 0 0 ANNETTE MOORE MD SECRETARY 0.50 0.00 X X 0 0 0 CHRIS LEMASTERS BOARD MEMBER 0.50 0.00 X 0 0 0 ANDREW MESECAR PHD BOARD MEMBER 0.50 0.00 X 0 0 0 BRIAN STEMME CEO 40.00 0.00 X 315884 0 53875 MARK INGOLD CFO 40.00 0.00 X 174284 0 26395 JEFF SMITH COO 40.00 0.00 X 148749 0 17999 KAREN DUTCHER GENERAL COUNSEL 40.00 0.00 X 149804 0 32483 LEAETTA HYER RESEARCH DEVELOPMENT OFFICER 40.00 0.00 X 136862 0 39467 CHRISTY YODER SAFETY AND REGULATORY OFFICER 40.00 0.00 X 122451 0 23544 ANITA CAMIC CONTRACTS AND QUALITY ASSURANCE OFFICER 40.00 0.00 X 115068 0 15575 LISA WOOD RESEARCH DEVELOPMENT DIRECTOR 40.00 0.00 X 113260 0 17358 1276362 633265 226696 9 0 1 0 0 387500 1409 1062 389971 RESEARCH SUPPORT 541700 14970336 14970336 14970336 332381 332381 1555167 1484498 70669 70669 70669 15763357 14970336 0 403050 X 724600 586926 137674 4022936 3273731 749205 187839 152858 34981 516651 420347 96304 346970 282173 64797 68 68 42100 42100 18210 18210 79467 29438 50029 97017 74155 22862 569850 368892 200958 426284 346675 79609 14554 6442 8112 84475 34500 49975 67364 54784 12580 60835 49474 11361 PATIENT CARE COST 4534387 4534387 OUTSIDE RESEARCH SERVIC 2730177 2730177 BAD DEBT EXPENSE 398615 398615 RESEARCH SUPPLIES 324271 324271 29998 276 29722 15276668 13668121 1608547 0 2674811 6444947 691820 4340434 6599017 682457 581142 125908 101315 2547644 4078349 1102740 757933 14561673 14903245 3157781 3454802 505259 266994 1133192 787005 4796232 4508801 X 9591604 10220607 173837 173837 9765441 10394444 14561673 14903245 486689 142314 0 X X 0 1 X 1 0 X X X 1 INDIANA UNIVERSITY 356001673 2 1 435616 0 1 435616 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 682457 581142 101315 101315 RIGHT OF USE ASSETS 757933 757933 LEASE LIABILITY 787005 787005 X 15887461 142314 142314 15745147 18210 18210 15763357 15258458 0 15258458 18210 18210 15276668 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE AND IS NOT CONSIDERED TO BE A PRIVATE FOUNDATION. CURRENT ACCOUNTING STANDARDS REQUIRE THE ORGANIZATION TO DISCLOSE THE AMOUNT OF POTENTIAL BENEFIT OR OBLIGATION TO BE REALIZED AS A RESULT OF AN EXAMINATION PERFORMED BY A TAXING AUTHORITY. FOR THE YEARS ENDED JUNE 30, 2025 AND 2024, MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION DOES NOT HAVE ANY TAX POSITIONS THAT RESULT IN ANY UNCERTAINTIES REGARDINGTHE POSSIBLE IMPACT ON THE ORGANIZATION'S FINANCIAL STATEMENTS. THE ORGANIZATION DOES NOT EXPECT THE TOTAL AMOUNT OF UNRECOGNIZED TAX BENEFITS TO SIGNIFICANTLY CHANGE IN THE NEXT 12 MONTHS. THE ORGANIZATION RECOGNIZES INTEREST AND/OR PENALTIES RELATED TO INCOME TAX MATTERS IN INCOME TAX EXPENSE. THE ORGANIZATION DID NOT HAVE ANY AMOUNTS ACCRUED FOR INTEREST AND PENALTIES AT JUNE 30, 2025 AND 2024. X X X 0 0 0 0 0 0 0 0 0 BRIAN STEMME CEO 300949 0 14935 0 0 0 14904 0 38971 0 369759 0 0 0 PATRICK LOEHRER MD BOARD MEMBER 0 248881 0 0 0 0 0 0 0 0 0 248881 0 0 MARK INGOLD CFO 158515 0 15769 0 0 0 8321 0 18074 0 200679 0 0 0 KAREN DUTCHER GENERAL COUNSEL 137567 0 12237 0 0 0 7443 0 25040 0 182287 0 0 0 LEAETTA HYER RESEARCH DEVELOPMENT OFFICER 121921 0 14941 0 0 0 6613 0 32854 0 176329 0 0 0 JEFF SMITH COO 131096 0 17653 0 0 0 7055 0 10944 0 166748 0 0 0 PART I, LINE 3 THE OFFICERS OF THE FINANCE COMMITTEE REVIEW AND APPROVE THE COMPENSATION OF THE CEO. THE BOARD USES PERFORMANCE REVIEW INFORMATION TO DETERMINE COMPENSATION, IN CONJUNCTION WITH COMPARABILITY DATA INCLUDING FORMS 990 OF OTHER ORGANIZATIONS. THIS PROCESS WAS LAST UNDERGONE IN 2025. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE SHALL BE COMPOSED ENTIRELY OF DIRECTORS. DURING INTERVALS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, THE EXECUTIVE COMMITTEE SHALL HAVE AND EXERCISE ALL OF THE AUTHORITY OF THE BOARD OF DIRECTORS IN THE MANAGEMENT OF THE CORPORATION, EXCEPT WHERE PROHIBITED BY LAW. IN ADDITION, THE EXECUTIVE COMMITTEE, TO THE EXTENT SPECIFIED BY THE BOARD OF DIRECTORS, MAY EXERCISE ANY OTHER AUTHORITY OF THE BOARD OF DIRECTORS AT SUCH OTHER TIMES, EXCEPT WHERE PROHIBITED BY LAW. FORM 990, PART VI, SECTION A, LINE 7A THE DIRECTOR OF THE INDIANA UNIVERSITY MELVIN AND BREN SIMON CANCER CENTER HAS AUTHORITY TO APPOINT A MAJORITY OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED IN DETAIL BY MANAGEMENT. THEN, A COPY OF THE FORM 990 IS PROVIDED TO THE CHAIRMAN FOR REVIEW BEFORE IT IS FILED WITH THE INTERNAL REVENUE SERVICE. AFTER FILLING, A COPY OF THE 990 IS MADE AVAILABLE TO ALL BOARD MEMBERS. FORM 990, PART VI, SECTION B, LINE 12C A WRITTEN CONFLICT OF INTEREST POLICY IS SIGNED BY THE BOARD OF DIRECTORS AND THE CEO ANNUALLY. THE CEO REVIEWS THEM AND DISCLOSES ANY REPORTED CONFLICTS OF INTEREST TO THE BOARD CHAIR. THE BOARD CHAIR ENSURES THAT ANY MEMBER WHO HAS A CONFLICT OF INTEREST ABSTAINS FROM VOTING ON ISSUES RELATED TO THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15A THE OFFICERS OF THE FINANCE COMMITTEE REVIEW AND APPROVE THE COMPENSATION OF THE CEO. THE BOARD USES PERFORMANCE REVIEW INFORMATION TO DETERMINE COMPENSATION, IN CONJUNCTION WITH COMPARABILITY DATA INCLUDING FORMS 990 OF OTHER ORGANIZATIONS. THIS PROCESS WAS LAST UNDERGONE IN 2025. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICIES ARE NOT REQUIRED DISCLOSURES PURSUANT TO INTERNAL REVENUE CODE (IRC) SECTION 6104. THESE DOCUMENTS ARE NOT AVAILABLE TO THE PUBLIC AT THIS TIME. FORM 990, PART IX, LINE 11G OTHER CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 29,438. MANAGEMENT AND GENERAL EXPENSES 50,029. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 79,467. FORM 990, PART IX, LINE 24E MISCELLANEOUS: PROGRAM SERVICE EXPENSES 276. MANAGEMENT AND GENERAL EXPENSES 29,722. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 29,998. FORM 990, PART XII, LINE 2C: THE PROCESS FOR OVERSIGHT AND SELECTION OF AN INDEPENDENT ACCOUNTANT HAS NOT CHANGED FROM THE PRIOR YEAR. INDIANA UNIVERSITY 400 E 7TH ST RM 501 BLOOMINGTON IN 47405 356001673 EDUCATION IN 501(C)(3) LINE 2 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0